Note: There is multimedia content on this page which requires the Flash viewer.
To see it, download and install the Flash plugin here:
Macromedia Flash Player
A new Duke University Medical Center study finds adding a new anti-viral drug to the standard therapy can cut the length of the treatment regimen for hepatitis C in half.
2:32 (mm:ss)